Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol in Glaucoma and Ocular Hypertension in India: A Multicenter, Open-Label, Phase 3 Study

INTRODUCTION: To evaluate the intraocular pressure (IOP)-lowering efficacy and safety of a triple fixed-combination of bimatoprost, brimonidine, and timolol (TFC) in patients with glaucoma or ocular hypertension (OHT) treated with fixed-combination or unfixed brimonidine and timolol therapy (dual-co...

Descripción completa

Detalles Bibliográficos
Autores principales: Menon, Meena G, Goodkin, Margot L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582300/
https://www.ncbi.nlm.nih.gov/pubmed/36274674
http://dx.doi.org/10.2147/OPTH.S369626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582300/
https://www.ncbi.nlm.nih.gov/pubmed/36274674
http://dx.doi.org/10.2147/OPTH.S369626

Ejemplares similares